AcouSort AB Cash Flow Conversion Efficiency
AcouSort AB cash flow conversion efficiency. Based on the latest financial reports, AcouSort AB (ACOU) has a cash flow conversion efficiency ratio of -0.473x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.64 Million ≈ $-499.55K USD) by net assets (Skr9.81 Million ≈ $1.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of AcouSort AB (2013–2025)
Cash flow conversion efficiency of AcouSort AB from 2013 to 2025. This chart illustrates how AcouSort AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ACOU share price today for real-time trading data and today's change.
AcouSort AB Cash Flow Conversion Ratio Explained
AcouSort AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
AcouSort AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AcouSort AB ranked by their cash flow conversion efficiency. Also see AcouSort AB market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Enlitic Inc
AU:ENL
|
-0.698x |
|
IMAGIS Co. Ltd
KQ:115610
|
-0.217x |
|
Liberty Defense Holdings, Ltd. Common Shares
NASDAQ:DETX
|
-0.788x |
|
Dr. Martens PLC
LSE:DOCS
|
0.392x |
|
Vineet Laboratories Limited
NSE:VINEETLAB
|
0.088x |
|
Synlogic Inc
NASDAQ:SYBX
|
-0.078x |
|
Teuza A Fairchild Technology Venture Ltd
TA:TUZA
|
-0.007x |
|
Lombard et Medot SA
PA:MLCAC
|
N/A |
Annual Cash Flow Conversion Efficiency for AcouSort AB (2013–2025)
The table below shows the annual cash flow conversion efficiency of AcouSort AB from 2013 to 2025. Review ACOU FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr16.30 Million ≈ $1.75 Million |
Skr-16.78 Million ≈ $-1.81 Million |
-1.029x | +53.68% |
| 2024-12-31 | Skr8.46 Million ≈ $910.75K |
Skr-18.81 Million ≈ $-2.02 Million |
-2.222x | -69.95% |
| 2023-12-31 | Skr24.14 Million ≈ $2.60 Million |
Skr-31.56 Million ≈ $-3.40 Million |
-1.308x | -763.33% |
| 2022-12-31 | Skr20.11 Million ≈ $2.16 Million |
Skr3.96 Million ≈ $426.70K |
0.197x | +159.62% |
| 2021-12-31 | Skr33.02 Million ≈ $3.55 Million |
Skr-10.92 Million ≈ $-1.17 Million |
-0.331x | +54.92% |
| 2020-12-31 | Skr9.59 Million ≈ $1.03 Million |
Skr-7.04 Million ≈ $-757.08K |
-0.733x | +55.87% |
| 2019-12-31 | Skr5.92 Million ≈ $637.30K |
Skr-9.84 Million ≈ $-1.06 Million |
-1.662x | -250.06% |
| 2018-12-31 | Skr15.58 Million ≈ $1.68 Million |
Skr-7.40 Million ≈ $-796.04K |
-0.475x | +78.37% |
| 2017-12-31 | Skr3.88 Million ≈ $417.87K |
Skr-8.53 Million ≈ $-917.43K |
-2.195x | -10113.03% |
| 2016-12-31 | Skr9.96 Million ≈ $1.07 Million |
Skr-214.00K ≈ $-23.03K |
-0.021x | +99.78% |
| 2015-12-31 | Skr78.63K ≈ $8.46K |
Skr-757.00K ≈ $-81.47K |
-9.627x | +57.84% |
| 2014-12-31 | Skr376.48K ≈ $40.52K |
Skr-8.60 Million ≈ $-925.17K |
-22.835x | -89.13% |
| 2013-12-31 | Skr249.47K ≈ $26.85K |
Skr-3.01 Million ≈ $-324.14K |
-12.074x | -- |
About AcouSort AB
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acous… Read more